Determination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS).
about
Determination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@ast
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@en
type
label
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@ast
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@en
prefLabel
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@ast
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@en
P2093
P2860
P1433
P1476
Determination of rivaroxaban i ...... ass Spectrometry (HPLC-MS/MS).
@en
P2093
Adriana Caschera Leme Faulhaber
Carlos Eduardo Dos Santos Ferreira
Carolina Nunes França
Claudio Ernesto Albers Mendes
João Carlos de Campos Guerra
Livia Rentas Sanches
Marcelo Katz
Marjorie Paris Colombini
Priscilla Bento Matos Derogis
Valdir Fernandes de Aranda
P2860
P304
P356
10.1371/JOURNAL.PONE.0171272
P407
P577
2017-02-07T00:00:00Z